As of November 2024 Helix Biopharma has 193.23M shares outstanding, a increase of 29.26% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 193.23M | 29.26% |
2022 | 149.49M | 8.41% |
2021 | 137.89M | 7.97% |
2020 | 127.71M | - |